Lilly (LLY) Inks Metabolic Disorders Therapy Development Deal

Published on December 13, 2021

Lilly (LLY) inks a strategic collaboration with Regor Therapeutics to discover and develop novel therapies for metabolic disorders.

Continue reading on website
Other news

To return, not to return, or almost to return: 5 tips to generate confidence when returning to the offices

December 13, 2021
Once the countries are finding answers to the epidemiological situation, they begin to raise the need for the social and to retake the face-to-face labor ties.

6 Deaths Confirmed After Tornado Hits Amazon Warehouse in Illinois

December 13, 2021
Witnesses said workers were caught off guard and had to seek shelter quickly.